The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair

Agnieszka Arthur, Andrew Zannettino, Stan Gronthos

Research output: Contribution to journalShort survey

244 Citations (Scopus)

Abstract

Four decades after the first isolation and characterization of clonogenic bone marrow stromal cells or mesenchymal stem cells (MSC) in the laboratory of Dr. Alexander Friedenstien, the therapeutic application of their progeny following ex vivo expansion are only now starting to be realized in the clinic. The multipotency, paracrine effects, and immune-modulatory properties of MSC present them as an ideal stem cell candidate for tissue engineering and regenerative medicine. In recent years it has come to light that MSC encompass plasticity that extends beyond the conventional bone, adipose, cartilage, and other skeletal structures, and has expanded to the differentiation of liver, kidney, muscle, skin, neural, and cardiac cell lineages. This review will specifically focus on the skeletal regenerative capacity of bone marrow derived MSC alone or in combination with growth factors, biocompatible scaffolds, and following genetic modification.

LanguageEnglish
Pages237-245
Number of pages9
JournalJournal of Cellular Physiology
Volume218
Issue number2
DOIs
Publication statusPublished - Feb 2009

ASJC Scopus subject areas

  • Medicine(all)
  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Arthur, Agnieszka ; Zannettino, Andrew ; Gronthos, Stan. / The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. In: Journal of Cellular Physiology. 2009 ; Vol. 218, No. 2. pp. 237-245.
@article{dc00294529cd4668beaf17ab00472d2c,
title = "The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair",
abstract = "Four decades after the first isolation and characterization of clonogenic bone marrow stromal cells or mesenchymal stem cells (MSC) in the laboratory of Dr. Alexander Friedenstien, the therapeutic application of their progeny following ex vivo expansion are only now starting to be realized in the clinic. The multipotency, paracrine effects, and immune-modulatory properties of MSC present them as an ideal stem cell candidate for tissue engineering and regenerative medicine. In recent years it has come to light that MSC encompass plasticity that extends beyond the conventional bone, adipose, cartilage, and other skeletal structures, and has expanded to the differentiation of liver, kidney, muscle, skin, neural, and cardiac cell lineages. This review will specifically focus on the skeletal regenerative capacity of bone marrow derived MSC alone or in combination with growth factors, biocompatible scaffolds, and following genetic modification.",
author = "Agnieszka Arthur and Andrew Zannettino and Stan Gronthos",
year = "2009",
month = "2",
doi = "10.1002/jcp.21592",
language = "English",
volume = "218",
pages = "237--245",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. / Arthur, Agnieszka; Zannettino, Andrew; Gronthos, Stan.

In: Journal of Cellular Physiology, Vol. 218, No. 2, 02.2009, p. 237-245.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair

AU - Arthur, Agnieszka

AU - Zannettino, Andrew

AU - Gronthos, Stan

PY - 2009/2

Y1 - 2009/2

N2 - Four decades after the first isolation and characterization of clonogenic bone marrow stromal cells or mesenchymal stem cells (MSC) in the laboratory of Dr. Alexander Friedenstien, the therapeutic application of their progeny following ex vivo expansion are only now starting to be realized in the clinic. The multipotency, paracrine effects, and immune-modulatory properties of MSC present them as an ideal stem cell candidate for tissue engineering and regenerative medicine. In recent years it has come to light that MSC encompass plasticity that extends beyond the conventional bone, adipose, cartilage, and other skeletal structures, and has expanded to the differentiation of liver, kidney, muscle, skin, neural, and cardiac cell lineages. This review will specifically focus on the skeletal regenerative capacity of bone marrow derived MSC alone or in combination with growth factors, biocompatible scaffolds, and following genetic modification.

AB - Four decades after the first isolation and characterization of clonogenic bone marrow stromal cells or mesenchymal stem cells (MSC) in the laboratory of Dr. Alexander Friedenstien, the therapeutic application of their progeny following ex vivo expansion are only now starting to be realized in the clinic. The multipotency, paracrine effects, and immune-modulatory properties of MSC present them as an ideal stem cell candidate for tissue engineering and regenerative medicine. In recent years it has come to light that MSC encompass plasticity that extends beyond the conventional bone, adipose, cartilage, and other skeletal structures, and has expanded to the differentiation of liver, kidney, muscle, skin, neural, and cardiac cell lineages. This review will specifically focus on the skeletal regenerative capacity of bone marrow derived MSC alone or in combination with growth factors, biocompatible scaffolds, and following genetic modification.

UR - http://www.scopus.com/inward/record.url?scp=58149265734&partnerID=8YFLogxK

U2 - 10.1002/jcp.21592

DO - 10.1002/jcp.21592

M3 - Short survey

VL - 218

SP - 237

EP - 245

JO - Journal of Cellular Physiology

T2 - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -